Medication
Wixela Inhub
DIN 02495619 · Mylan Pharmaceuticals ULC
What it is
- Active ingredients
- Fluticasone Propionate — 500 mcg
- Salmeterol — 50 mcg
- Form and route
- Powder · Inhalation
- Schedule
- PRESCRIPTION
- Authorised since
- 2020-02-13
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Respiratory system
- ATC code
- R03AK06
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of R03AK06, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.